TREATMENT OUTCOMES OF CHRONIC URTICARIA USING THREAD EMBEDDING THERAPY AT HANOI DERMATOLOGY HOSPITAL

Minh Phương Nguyễn, Đức Chiến Nguyễn, Phương Trang Nguyễn

Main Article Content

Abstract

Objective: To evaluate the results of chronic urticaria treatment by thread embedding therapy at Hanoi Dermatology Hospital in 2024 and measure the quality of life of patients before and after thread embedding therapy treatment. Subjects and methods: A pre-post intervention study was conducted on 33 patients with chronic urticaria at Hanoi Dermatology Hospital during May-October 2024. The acupuncture points include Quchi, Xuehai, Zusanli, Neiguan, Wenliu, Hegu, Sanyinjiao, Feiyang, Gandu, and Fengchi. The thread embedding procedure was 4 times (each time 2 weeks apart); Monitor and evaluate clinical symptoms (itching, number of wheals, size, frequency, duration of lesions), severity (TSS), urticaria activity (UAS7), quality of life (CU-Q2oL), satisfaction, complications and recurrence. Results: After 4 and 8 weeks of treatment, all symptom indices decreased significantly (p<0.001 compared to before treatment), TSS decreased from 9.97±0.17 to 3.0±0.03 (p<0.001), UAS7 score decreased from 17.76±9.83 to 1.45±2.00 (p<0.001), CU-Q2oL score decreased from 40.10±6.40 to 5.42±8.76 (p<0.001). The rate of mild patients increased from 0% to 75.8%, with no more severe cases. After 8 weeks of treatment, 87.9% of patients were satisfied - very satisfied. The main complications were edema, pain and swelling at the implant site (51.5%). Recurrence occurred in 7.7% after 4 weeks and 20% after 8 weeks of stopping treatment. Conclusion: The thread embedding is safe and effective in significantly improving symptoms and quality of life for patients with chronic urticaria. Combining thread embedding in the treatment regimen for chronic urticaria is a good approach to achieve the goal of reducing symptoms and improving quality of life for patients.

Article Details

References

1. Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. 2010;35(8):869-873.
2. Nguyễn Năng An. Mày đay và phù Quincke. In: Bách khoa thư bệnh học. tập 3. Nhà xuất bản Từ điển Bách khoa; 2000:266-269.
3. Chow SKW, Wong CKH, Leung P, et al. Management of chronic urticaria in Asia: 2010 AADV consensus guidelines. Asia Pac Allergy. 2012;2(2):149-160.
4. Bộ Y tế – Vụ Y học Cổ truyền. Hướng dẫn chẩn đoán và điều trị bệnh theo y học cổ truyền. Bộ Y tế; 2017:135.
5. Bộ Y tế. Quyết định số 5480/QĐ-BYT ngày 30/12/2020 ban hành Tài liệu chuyên môn Hướng dẫn Quy trình kỹ thuật chuyên ngành Y học cổ truyền. Bộ Y tế; 2020:93-95.
6. Kaplan AP. Clinical practice: Chronic urticaria and angioedema, The New England journal of medicine, 2002;346(3):175-179
7. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2)LEN/EDF/WAO guideline for the difinition, classification, diagnosis and managenment of urticaria. Allergy. 2018;73(7):1393-1414.
8. Nguyễn Thị Quỳnh Trang, Bùi Phương Linh, Nguyễn Thị Hải Yến, Nguyễn Thanh Hà. Hiệu quả điều trị mày đay mạn tính bằng desloratadin kết hợp montelukast. Tạp chí dược lâm sàng 108. 2024;19(1):82-89.
9. Nguyễn Thị Hồng Ngọc. Nồng độ Vitamin D huyết thanh trên bệnh nhân mề đay mạn tính đến khám tại Bệnh viện Da liễu Thành phố Hồ Chí Minh. [Luận văn thạc sĩ Y học]. Đại học Y dược Thành phố Hồ Chí Minh; 2016.